The importance of lymphocyte trafficking in regulating blood lymphocyte levels during HIV and SIV infections

Seminars in Immunology

Volumn 11, Issue 2, 1999, Pages 139-154

  Rosenberg, Yvonne J ^a   Janossy, George ^b  

^a 6701 Democracy Blvd 201   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

HIV; Selectivity; SIV; T cells; Trafficking

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; PROTEINASE INHIBITOR;

ARTICLE; BLOOD; CELL KILLING; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE STATUS; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; LEUKOCYTE COUNT; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; TISSUE DISTRIBUTION; VIRUS; VIRUS INFECTION;

EID: 0032957320     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1999.0169     Document Type: Article

References (113)

1. Roederer M, De Ross SC, Herzenberg LA. Kresina T. Immune Modulating Agents. 1996;209-220 Marcel Dekker, New York.
2. + T cells. J Exp Med. 186:1997;1407-1418.
3. Lundqvist C, Baranov V, Hammarstrom S, Athlin L, Hammarstrom M-L. Intra-epithelial lymphocytes. Evidence for regional specialization and extrathymic T cell maturation in the human gut epithelium. Int Immunol. 7:1995;1473-1487.
4. Westermann J, Pabst R. Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol Today. 11:1990;406-409.
5. Westermann J, Ronneberg S, Joachim Fritz F, Pabst R. Proliferation of lymphocyte subsets in the adult rat: a comparison of different lymphoid organs. Eur J Immunol. 19:1989;1087-1093.
6. Mackall CL, Hakim FT, Gress RE. Restoration of T-cell homeostasis after T-cell depletion. Sem Immunol. 9:1997;339-346.
7. + subsets in acute Epstein-Barr virus infection: comparison with chronic human immunodeficiency virus disease. J Infect Dis. 177:1998;1083-1087.
8. (+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol. 11:1991;345-356.
9. Rosenberg YJ, Anderson AO, Pabst R. HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking. Immunol Today. 19:1998;10-17.
10. Westermann J, Pabst R. Distribution of lymphocyte subsets and natural killer cells in the human body. Clin Invest. 70:1992;539-544.
11. + lymphocyte population in the blood of SIV-infected macaques is not reflected in the lymph node. AIDS Res Human Retroviruses. 9:1992;639-646.
12. Doherty PC, Hamilton-Easton A-M, Topham DJ, Ribwerdy J, Brooks JW, Cardin R. Consequences of viral infections for lymphocyte compartmentalization and homeostasis. Sem Immunol. 9:1998;365-373.
13. + lymphocytes in cynomolgus monkeys are of resting memory T lineage. Int Immunol. 9:1997;591-597.
14. Sparshott SM, Bell EB. Membrane CD45R isoform exchange on CD4 T cells is rapid, frequent and dynamic in vivo. Eur J Immunol. 24:1994;2573-2578.
15. Azuma A, Phillips JH, Lanier L. CD28-lymphocytes. Antigenic and functional properties. J Immunol. 150:1993;1147-1159.
16. +T lymphocytes are enriched in antigen-specific T cells capable of downmodulating cytotoxic activity. Int Immunol. 10:1998;311-323.
17. + counterparts. J Immunol. 156:1996;3587-3590.
18. - T cells. AIDS. 8:1994;4312-4441.
19. Roederer M, DeRosa SC, Watanabe N, Herzenberg LA. Dynamics of fine T-cell subsets during disease and after thymic ablation by mediastinal irradiation. Sem Immunol. 9:1997;389-396.
20. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type 1 interferon in vivo. Science. 272:1996;1947-1950.
21. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med. 187:1998;1395-1402.
22. Giorgi JV, Janossy G. Flow cytometric studies in HIV disease: relevance to AIDS vaccine development. AIDS. 8:1994;183-193.
23. Ferbas J, Daar E, Grovitt-Ferbas K, Lech WJ, Detels R, Giorgi JV, Kap lan AH. Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection. J Virol. 70:1998;7285-7289.
24. Margolick JB, Donnenberg AD. T-cell homeostasis in HIV-1 infection. Sem Immunol. 9:1997;381-388.
25. Roos MTL, de Leeuw NASM, Claessen FAP, Huisman HG, Kootstra NA, Meyaard L, Schellekens PTA, Schuitemaker H, Miedema F. Viro-immunological studies in acute HIV-1 infection. AIDS. 8:1994;1533-1538.
26. - induced acute death in macaques. J Med Primatol. 20:1991;206-210.
27. Gartner S, Polonis V, Lewis MG, Elkins WR, Hunter EA, Miao J, Corts KJ, Eddy GA. Adaptation of HIV-1 to pigtailed macaques. J Med Primatol. 23:1994;155-163.
28. Hirsch, VM, Dapolito, G, Johnson, PR, Elkins, WR, London, WT, Montali, RJ, Goldstein, S, Brown, C, (, 1995, ), Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo rep.
29. Lewis MG, Zack PM, Elkins WR, Jahrling PB. Infection of rhesus and cynomolgus macaques with a rapidly fatal SIV (SIVsmm/pbj) isolate from sooty mangabeys. AIDS Res Human Retroviruses. 8:1992;1631-1639.
30. Westermann J, Persin S, Matyas J, van der Meide P, Pabst R. IFN-g influences the migration of thoracic duct B and T lymphocyte subsets in vivo. Random increase in disappearance from the blood and differential decrease in reappearance in the lymph. J Immunol. 150:1993;3843-3852.
31. Michle CA, McLean A, Alcock C, Beverley PCL. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature. 360:1992;264-265.
32. Pabst R, Rosenberg YJ. Interpreting data on lymphocyte subsets in the blood of HIV patients - organ distribution, proliferation and migration kinetics are critical factors. Pathobiology. 66:1998;117-122.
33. Diaz-Gonzalez F, Sanchez-Masdrid F. Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs. Immunol Today. 19:1998;169-172.
34. Born J, Lange T, Hansen K, Molle M, Fehm H-L. Effects of sleep and circadian rhythm on circulating immune cells. J Immunol. 158:1997;4454-4464.
35. + lymphocyte counts with rest; implications for the monitoring of HIV infection. Int J STD AIDS. 8:1997;423-426.
36. dim natural killer subsets. J Immunol. 161:1998;400-408.
37. Watanabe N, De Rosa SC, Cmelak A, Hoppe R, Herzenberg LA, Roederer M. Long term depletion of naive T cells in patients treated for Hodgkin's disease. Blood. 90:1997;3682-3672.
38. + cells: a reevaluation of bystander activation during viral infection. Immunity. 8:1998;177-187.
39. Kuroda MJ, Schmitz JE, Barouch DH, Craiu A, Allen TM, Sette A, Watkins DJ, Forman MA, Letvin NL. Analysis of gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class 1-peptide complex. J Exp Med. 187:1998;1373-1381.
40. + lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions. Am J Respir Crit Care Med. 149:1994;972-980.
41. Autran B, Giorgi J. Janossy G, Autran B, Miedema F. Immunodeficiency in HIV infection and AIDS. 1992;171-184 Karger, Basel
42. Westermann J, Pabst R. How organ-specific is the migration of 'naive' and 'memory' T cells? Immunol Today. 17:1996;278-282.
43. Ebnet K, Kaldjain EP, Anderson AO, Shaw S. Orchestrated information transfer underlying leukocyte endothelial interactions. Annu Rev Immunol. 14:1996;155-177.
44. - T cells from rheumatoid arthritis patients. J Immunol. 161:1998;1018-1025.
45. Rosenberg YJ, Zack PM, Leon EC, White BD, Papermaster SF, Hall E, Greenhouse JJ, Eddy GA, Lewis MG. Immunological and virological changes associated with the decline in the CD4/CD8 ratios in lymphoid organs of SIV infected macaques. AIDS Res Human Retroviruses. 19:1994;863-872.
46. Pitzalis C, Kingsly GH, Covelli M, Meliconi R, Markey A, Panayi GS. Eur J Immunol. 21:1991;368-376.
47. + population in lymph nodes does not reflect that in the blood during SIVmne/E11s infection of macaques. J Med Primatol. 21:1992;131-137.
48. Pabst R. The spleen in lymphocyte migration. Immunol Today. 9:1988;43-45.
49. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV infection. Nature. 373:1995;123-126.
50. smmPBj14. Virology. 225:1996;21-32.
51. Finkel TH, Tudor Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupper A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1:1995;129-134.
52. Chun T-W, Carruth L, Finzl D, Shen X, DiGiuseppe A, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo Y-H, Brookmeyer R, Zieger MA, Barditch-Crovo P, Silliciano RF. Quantification of latent reservoirs and total body viral load in HIV-1 infection. Nature. 387:1997;182-188.
53. De Luca C, Kwon H, Pelletier N, Wainberg MA, Hiscott J. NK-kappa B protects HIV-1 infected myeloid cells from apoptosis. Virology. 244:1998;27-38.
54. + T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res Human Retroviruses. 13:1998;461-471.
55. Haase AT, Henry K, Zupanzcic M, Sedgewick G, Faust RA, Melroe H, Cavert W, Gebhard K, Staskus K, Zhang Z-Q, Dailey PJ, Balfour HH, Jr, Erice A, Perelson AS. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science. 274:1996;985-989.
56. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annual Rev Physiol. 57:1995;827-872.
57. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 272:1996;60-66.
58. Hay JB, Abernathy NJ, Kalaaji AN, Teare GF, Borron P. Beh KJ. Animal health and production for the 21st century. 1993;103-110 CSIRO, Australia.
59. Manning AM, Bell FP, Rosenbloom CL, Chosay JG, Simmons CA, Northrup JL, Shebuski RJ, Dunn CJ, Anderson DC. NF-kappa B is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment. J Inflamm. 45:1995;283-296.
60. Suguri T, Kikuta A, Iwagaki H, Yoshino T, Tanaka N, Orita K. Increased plasma GlyCAM1-1, a mouse L-selectin ligand, in response to an inflammatory stimulus. J Leukocyte Biol. 60:1996;593-597.
61. Sata M, Walsh K. TNFa regulation of fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat Med. 4:1998;413-420.
62. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Interferon-g concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. J Acquir Immune Defic Syndr. 2:1989;158-162.
63. Emilie D, Peuchmaur M, Maillot MC, Crevon MC, Brousse N, Delfraissy JF, Dormont J. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest. 86:1990;148-159.
64. Persidsky Y, Steffan AM, Gendrault JL, Royer C, Beyer C, Muchmore E, Kirn A, Aubertin AM. Morphological changes in lymph nodes and expression of VCAM1 and cytokines at the late stages of SIV-induced disease in rhesus monkeys. Res Virol. 146:1995;185-200.
65. Racz P, Tenner-Racz K, van Vloten F, Razzaque Ali A, Dietrich M, Gluckman JC. Schonfeld H. Antibiotics and chemotherapy. 1991;201-213 Karger, Basel.
66. Tenner-Racz K, Stellbrink H-J, van Lunzen J, Schneider C, Jacobs J-P, Raschdorff B, Grossschupff G, Steinman RM, Racz P. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med. 187:1998;40-959.
67. Wang L, Robb CW, Cloyd MW. HIV induces homing of resting T lymphocytes to lymph nodes. Virology. 228:1997;141-152.
68. + lymphocytes. Proc Natl Acad Sci USA. 86:1989;3301-3305.
69. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science. 278:1997;672-675.
70. Tindall B, Cooper DA. Primary HIV infection: host responses and intervention and intervention strategies. AIDS. 5:1991;1-14.
71. Rosenberg YJ, Cafaro A, Brennan T, Greenhouse JG, Villinger F, Ansari AA, Brown C, McKinnon K, Bellah S, Yalley-ogunro J, Elkins WR, Gartner S, Lewis MG. Virus-induced cytokines regulate circulating lymphocyte levels during primary SIV infections. Int Immunol. 9:1997;703-712.
72. + lymphocytosis during primary simian immunodeficiency virus infections. AIDS. 11:1997;959-968.
73. - T cell subsets in HIV type 1-infected individuals. Eur J Immunol. 28:1998;1738-1742.
74. Janossy G, Beckess M, Tilling R, Johnson MA, Poulter LW. Lymphocyte and monocyte subset changes during HIV infections in blood, lymph nodes and lung. 5th Conference on Retrovir Opp Infections. 607:1998;194.
75. Oksenhendler E, Autran B, Gorochov G, d'Agay MF, Seligman M, Clauvel J-P. CD8 lymphocytosis and pseudotumeral splenomegaly. Lancet. 340:1992;207-208.
76. - cell population in the blood and lung of HIV-positive patients. J Acquir Immune Defic Syndr. 6:1993;1194-1204.
77. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 280:1998;243-248.
78. Sprent J, Tough DF. Lymphocyte life-span and memory. Science. 265:1994;1395-1400.
79. Koup RA, Safrit JT, Cao Y, Abdrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 68:1994;4650-4655.
80. + T cells with a predominant Vb usage during the primary immune response to HIV. Nature. 370:1994;463-467.
81. + T cells. Science. 270:1995;1811-1815.
82. + cell anti-HIV activity: Nonlytic suppression of virus replication. AIDS Res Human Retroviruses. 8:1992;1039-1050.
83. Hulstaert F, Strauss K, Levacher M, Vanham G, Kestens L, Allen Bach B. Janossy G, Autran B, Miedema F. Immunodeficiency in HIV infection and AIDS. 1992;185-194 Karger, Basel.
84. Racz P, Tenner-Racz K, van Vloten F, Letvin NL, Janossy G. Racz P, Letvin NL, Gluckman JC. Cytotoxic T cells in HIV and other retroviral infections. 1992;162-173 Karger, Basel.
85. Janossy G, Jiang JD, Roboz JP, Bofill M, Bekesi JG. Janossy G, Autran B, Miedema F. Immunodeficiency in HIV infection and AIDS. 1992;195-210 Karger, Basel.
86. Akbar AN, Borthwick N, Salmon M, Gombert W, Bofill M, Shamsadeen N, P illing D, Pett S, Grundy JE, Janossy G. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med. 178:1993;427-434.
87. + patients. Am J Pathol. 146:1995;1542-1550.
88. Rosenberg YJ, Lewis MG, Greenhouse JJ, Cafaro A, Leon EC, Brown CR, Bieg KE, Kosco-Vilbois MH. Enhanced follicular dendritic cell function in lymph nodes of simian immunodeficiency virus-infected macaques: consequences for pathogenesis. Eur J Immunol. 27:1997.
89. + lymphocytes in lymph nodes of human immunodeficiency virus-1 infected patients. Am J Pathol. 142:1993;1750-1758.
90. Pantaleo G, Sondeyns H, Demarest JF, Vaccarezza M, Graziosi C, Paulucci S, Daucher M-B, Cohen OJ, Denis F, Biddison WE, Sekaly RF, Fauci AS. Accumulation of human immunodeficiency virus-specific T lymphocytes away from the predominant site of virus replication during primary infection. Eur J Immunol. 27:1997;3166-3173.
91. Andersson J, Fehniger TE, Parrerson BK, Pattage J, Agnoli M, Jones P, Behbahani H, Landay L. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS. 12:1998.
92. Tedla N, Palladinetti P, Kelly M, Kumar RK, Girolamo N, Chattophadhay U, Cooke B, Truskett P, Dwyer J, Wakefield D, Lloyd A. Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. Am J Pathol. 148:1996;1367-1373.
93. Janossy G, Pinching AJ, Bofill M, Weber J, McLaughlin JE, Ornstein M, Ivory K, Harris JR, Favrot M, Macdonald-Burns DC. An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS. Clin Exp Immunol. 59:1985;257-266.
94. Rosok BI, Bostad L, Voltersvik R, Olofsson J, Asjo B, Brinchman JE. Reduced CD4 cell counts in blood do not reflect CD4 cell depletion in tonsillar tissue in asymptomatic HIV-1 infection. AIDS. 10:1996.
95. + T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci USA. 95:1998;1154-1159.
96. + T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. Proc Natl Acad Sci USA. 17:1998;3111-3116.
97. Livingstone WJ, Moore M, Innes D, Bell JE, Simmonds P. Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV. Lancet 348:649-654, 274:1996;1543.
98. Trono D. HIV accessory proteins: leading roles for the supporting cast. Cell. 82:1995;189-192.
99. Geleziunas R, Bour S, Wainberg MA. Cell surface down-modulation of CD4 after infection by HIV-1. FASEB J. 8:1994;593-600.
100. + T-cell regeneration in HIV-infected adults. Nat Med. 4:1998;852-856.
101. Grossman Z, Bentwich Z, Herberman RB. From HIV infection to AIDS: are the manifestations of effective immune resistance misinterpreted? Clin Immunol Immunopathol. 69:1993;123-135.
102. McCune JM, Loftus R, Schmidt DK, Carrol P, Webster D, Swor-Yim LB, Francis IR, Gross BH, Grant RM. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest. 101:1998;2301-2308.
103. + T-cell memory, CD45RA subsets and the persistence of antigen - a unifying concept. Immunol Today. 19:1998;60-64.
104. Perrin L, Telenti A. HIV treatment failure: testing for HIV resistance in clinical practice. Science. 280:1998;1871-1873.
105. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonivir. J Infect Dis. 173:1996;321-329.
106. + T cell homeostasis and function in advanced HIV disease. Science. 277:1997;112-116.
107. Pakker NG, Notermans DW, De Boer R, Roos MTL, de Wolf F, Hill A, Leonard JM, Danner SA, Miedema F, Schellekens PTA. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med. 4:1998;208-214.
108. Silvestri G, Munoz C, Butini L, Bagnarelli P, Montroni M. Changes in CD8 cell subpopulations induced by antiretroviral therapy in human immunodeficiency virus infected patients. Viral Immunol. 10:1997;207-212.
109. Carcelain G, Blanc C, Debre P, Mathez D, Saimot AG, Liebowitch J, Autran B. Correction of immunological disorders with highly active antiretroviral therapies (HAART) of acute HIV infection. 5th Conference on Retroviruses and Opportunistic infections Abst. 167:1998;110.
110. Bonhoeffer S, Monard S, Perelson AS, Ho DD. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science. 279:1998;1223-1227.
111. + T lymphocytes turnover in simian immunodeficiency virus-infected macaques. Proc Natl Acad Sci USA. 95:1998;6388-6398.
112. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt DS, Hoh R, Neese R, Macallan D, Deeks S, McCune JM. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med. 1998.
113. + cell turnover. Science. 274:1996;1543-1547.